Dear Colleagues,

We are excited to invite you to the 3rd edition of the Cardiovascular, Renal, Metabolic, Liver, and Obesity Conference (CaReMeLO 2026), taking place in Munich, Germany, on 8-9 May 2026.

Following the tremendous success of the second edition of the CaReMeLO conference in Warsaw in 2025, which saw over 1000 participants, we are building on this momentum to further empower family physicians in the comprehensive management of cardiovascular, renal, metabolic, liver and obesity conditions. In 2026, This upcoming conference will continue to highlight the pivotal role of family physicians in the integrated management of cardiometabolic, renal, liver, and obesity-related conditions, offering the latest scientific insights, practical tools, and international perspectives tailored to primary care.

This year, we are placing a greater emphasis on cutting-edge therapies and in addition, we will be highlighting the critical role of vaccination in high-risk populations—an often under-addressed but essential aspect of managing cardiometabolic and liver diseases.

The 2026 edition promises to deliver an even more dynamic and impactful experience, incorporating feedback from last year. Expect more interactive sessions, practical real world case studies, and enriched networking opportunities, as well as deeper explorations of the latest treatments and innovations in managing obesity and liver disease.

This conference is vital for family physicians, general practitioners, nurse practitioners, and specialists in endocrinology, cardiology, and nephrology. If you are involved in managing patients with cardiometabolic and obesity syndromes, this event is designed for you.

Join us in Munich to explore innovative strategies and strengthen your expertise in managing CaReMeLO syndromes. This is your opportunity to make a lasting impact on patient care and outcomes. Stay tuned for more details about this essential event for primary care providers and specialists.

We eagerly anticipate welcoming you to CaReMeLO 2026 in Munich!

On behalf of the Scientific Committee,

Prof. Avraham Karasik
Co-Chair of CaReMeLO, Professor of Medicine (Emeritus), Tel Aviv University, Israel

Dr. Baruch Itzhak
Co-Chair of CaReMeLO, Specialist in Family Medicine, Diabetologist, Clalit Health Services, Technion Faculty of Medicine, Haifa, Israel

Prof. Josep Vilaseca
Co-Chair of CaReMeLO, General Practitioner/ Family Doctor, University of Vic – Central Catalonia University; Althaia Foundation, Spain

Prof. Thomas Frese
Co-Chair of CaReMeLO, Presiden of WONCA Europe starting 2025, Director of the Institute of General Medicine, Medical Faculty of Leipzig, Germany 

Prof. Shlomo Vinker
Co-Chair of CaReMeLO, President of  WONCA Europe from 2021-2025, Executive member of EGPRN, Tel Aviv University, Istael

Prof. Eberhard Standl
Co-Chair of CaReMeLO, Endocrinologist/Angiologist, Munich Diabetes Research Group Helmholtz Centre, Germany

Prof. Oliver Schnell
Co-Chair of CaReMeLO, Founder and Managing Director of Sciarc GmbH, Munich, Germany 

Prof. Jörg Schelling
Co-Chair of CaReMeLO, Specialist in General Medicine, Hausärztliche Gemeinschaftspraxis Martinsried, Germany